home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

54 rows where docket_id = "FDA-2000-D-0187" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 6

  • 2025 27
  • 2020 20
  • 2012 2
  • 2013 2
  • 2022 2
  • 2000 1

document_type 3

  • Supporting & Related Material 42
  • Notice 6
  • Other 6

agency_id 1

  • FDA 54
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2000-D-0187-0052 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 5 - Malaria _ CDC Yellow Book 2024 Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:55:21Z   0 0 09000064868c15dc
FDA-2000-D-0187-0057 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 10 - Mungai M Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:56:15Z   0 0 09000064868c15e1
FDA-2000-D-0187-0053 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 6 - Local Transmission of I Plasmodium vivax I Malaria --- Palm Beach County Florida 2003 Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:55:34Z   0 0 09000064868c15dd
FDA-2000-D-0187-0065 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 18 - Khan J Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:57:36Z   0 0 09000064868c15f5
FDA-2000-D-0187-0072 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Draft Guidance for Industry Other Guidance 2025-01-16T05:00:00Z 2025 1 2025-01-16T05:00:00Z 2025-03-18T03:59:59Z 2025-03-22T01:00:44Z   1 0 09000064868c694a
FDA-2000-D-0187-0050 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 3 - Doolan D Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:55:01Z   0 0 09000064868c156b
FDA-2000-D-0187-0062 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 15 - Stubbs L Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:57:09Z   0 0 09000064868c15f2
FDA-2000-D-0187-0064 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 17 - Dike A Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:57:27Z   0 0 09000064868c15f4
FDA-2000-D-0187-0056 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 9 - Muneer A Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:56:04Z   0 0 09000064868c15e0
FDA-2000-D-0187-0049 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 2 - World Malaria Report 2022 Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:54:49Z   0 0 09000064868c156a
FDA-2000-D-0187-0070 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 23 Malaria Surveillance United States 2016 MMWR Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:58:21Z   0 0 09000064868c161c
FDA-2000-D-0187-0051 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 4 - Mace K Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:55:11Z   0 0 09000064868c15db
FDA-2000-D-0187-0059 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 12 - Uneke C Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:56:37Z   0 0 09000064868c15e3
FDA-2000-D-0187-0063 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 16 - Neiderhauer C Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:57:18Z   0 0 09000064868c15f3
FDA-2000-D-0187-0061 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 14 - Anand A Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:56:57Z   0 0 09000064868c15f1
FDA-2000-D-0187-0054 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 7 - Blackburn D Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:55:44Z   0 0 09000064868c15de
FDA-2000-D-0187-0066 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 19 - Israelyan N Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:57:46Z   0 0 09000064868c15f6
FDA-2000-D-0187-0048 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 1 -Guidance for Industry. Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:54:30Z   0 0 09000064868c1569
FDA-2000-D-0187-0055 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 8 - Duwell M Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:55:54Z   0 0 09000064868c15df
FDA-2000-D-0187-0071 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference-24 Malaria Surveillance United States 2017 MMWR Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:58:29Z   0 0 09000064868c161d
FDA-2000-D-0187-0069 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 22-MalariaRBDMAnalysis_FINAL_2024-05-28 Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:58:13Z   0 0 09000064868c15f9
FDA-2000-D-0187-0060 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 13 - Katz L Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:56:49Z   0 0 09000064868c15e4
FDA-2000-D-0187-0068 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 21- Blood Products Advisory Committee May 9.. Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:58:04Z   0 0 09000064868c15f8
FDA-2000-D-0187-0067 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference 20 - cobas Malaria _ FDA Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:57:55Z   0 0 09000064868c15f7
FDA-2000-D-0187-0047 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 References Supporting & Related Material Background Material 2025-01-16T05:00:00Z 2025 1     2025-01-16T16:54:14Z   0 0 09000064868c1568
FDA-2000-D-0187-0046 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Draft Guidance for Industry; Availability Notice Notice of Availability 2025-01-16T05:00:00Z 2025 1 2025-01-16T05:00:00Z   2025-01-24T18:59:15Z 2025-01028 0 0 09000064868c6752
FDA-2000-D-0187-0058 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Malaria Guidance 2024-434 Supporting & Related Material   2025-01-16T00:00:00Z 2025 1     2025-01-16T17:11:32Z   0 1 09000064868c15e2
FDA-2000-D-0187-0044 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability Notice Notice of Availability 2022-12-08T05:00:00Z 2022 12 2022-12-08T05:00:00Z   2022-12-08T15:46:19Z 2022-26711 0 0 0900006485524919
FDA-2000-D-0187-0045 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry - Final Guidance Other Guidance 2022-12-08T05:00:00Z 2022 12 2022-12-08T05:00:00Z   2024-11-07T00:45:38Z   1 0 090000648552199f
FDA-2000-D-0187-0031 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 4 Mace KE et al - MMWR 2017 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:02:06Z   0 0 09000064846f6952
FDA-2000-D-0187-0030 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 3 - OBrien SF - Transfusion medicine reviews 2015 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:01:54Z   0 0 09000064846f6951
FDA-2000-D-0187-0043 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 15 FDA BPAC Transcripts 111609 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:05:11Z   0 0 09000064846f69b0
FDA-2000-D-0187-0026 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Other Guidance 2020-06-17T04:00:00Z 2020 6 2020-06-17T04:00:00Z   2022-12-08T15:47:25Z   0 0 09000064846f6586
FDA-2000-D-0187-0027 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Reference List Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:00:39Z   0 0 09000064846f658e
FDA-2000-D-0187-0039 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 11 Doolan D L et al Acquired immunity to malaria Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:04:15Z   0 0 09000064846f69ac
FDA-2000-D-0187-0033 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 5 - Mace KE et al - MMWR 2018Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:02:37Z   0 0 09000064846f697e
FDA-2000-D-0187-0036 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 8 - Reesink et al - Transfusion 2010 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:03:23Z   0 0 09000064846f6981
FDA-2000-D-0187-0041 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 13 FDA Workshop Testing for malarial infections in blood donors July 12 2006 FDA Blood Products Advisory Committee Testing for malarial infections in blood donors July 13 2006 Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:04:50Z   0 0 09000064846f69ae
FDA-2000-D-0187-0029 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 2 - Mungai M et al - NEJM 2001 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:01:44Z   0 0 09000064846f6950
FDA-2000-D-0187-0035 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 7 Spencer B et al Risk for malaria in United States donors deferred for travel to malaria endemic areas Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:03:14Z   0 0 09000064846f6980
FDA-2000-D-0187-0032 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 5 - Mace KE et al - MMWR 2018 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:02:16Z   0 0 09000064846f6953
FDA-2000-D-0187-0034 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 6 - Mace KE et al - MMWR 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:03:00Z   0 0 09000064846f697f
FDA-2000-D-0187-0037 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 9 - Spenser B et al - Transfusion Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:03:35Z   0 0 09000064846f6982
FDA-2000-D-0187-0042 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 14 FDA Blood Products Advisory Committee - Sept 2008 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:05:00Z   0 0 09000064846f69af
FDA-2000-D-0187-0038 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 10 Liljander A et al Influences of intermittent preventive treatment and persistent multiclonal Plasmodium falciparum in-1 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:03:48Z   0 0 09000064846f6983
FDA-2000-D-0187-0028 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 1 - Katz LM & Spenser BR - AABB Press 2019 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:00:59Z   0 0 09000064846f694f
FDA-2000-D-0187-0025 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Revised Recommendations To Reduce the Risk of Transfusion-Transmitted Malaria; Guidance for Industry; Availability Notice Notice of Availability 2020-06-17T04:00:00Z 2020 6 2020-06-17T04:00:00Z   2020-06-17T13:13:25Z 2020-13066 0 0 09000064846f5e19
FDA-2000-D-0187-0040 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Ref 12 - Nguyen ML et al - Transfusion 2013 Re: Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Supporting & Related Material Background Material 2020-06-17T04:00:00Z 2020 6     2020-06-17T15:04:26Z   0 0 09000064846f69ad
FDA-2000-D-0187-0024 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Revised Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria Guidance for Industry Other Guidance 2020-04-03T04:00:00Z 2020 4 2020-04-03T04:00:00Z   2024-11-06T23:34:52Z   1 0 0900006484485685
FDA-2000-D-0187-0021 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Guidance for Industry: Recommendations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria; Availability Notice Notice of Availability 2013-08-19T04:00:00Z 2013 8 2013-08-19T04:00:00Z   2013-08-19T14:42:09Z 2013-19962 0 0 09000064813b8a55
FDA-2000-D-0187-0022 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Recommendations for Donor Questioning, Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria: Guidance for Industry Other Guidance 2013-08-01T04:00:00Z 2013 8 2013-08-01T04:00:00Z   2022-12-08T15:47:42Z   0 0 09000064813b9117
FDA-2000-D-0187-0003 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Draft Guidance for Industry Recommedations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce Risk of Transfusion-Transmitted Malaria Other Guidance 2012-07-06T04:00:00Z 2012 7 2012-07-06T04:00:00Z 2012-09-05T03:59:59Z 2024-11-07T22:45:32Z   1 0 090000648107d6f4
FDA-2000-D-0187-0002 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 Draft Guidance for Industry:Recommedations for Donor Questioning, Deferral, Reentry, and Product Management to Reduce Risk of Transfusion-Transmitted Malaria; Availability Notice Notice of Data Availability 2012-07-06T04:00:00Z 2012 7 2012-07-06T04:00:00Z 2012-09-05T03:59:59Z 2012-09-07T02:01:07Z 2012-16528 0 0 090000648107d34d
FDA-2000-D-0187-0001 FDA Recommendations for Donor Questioning Regarding Malaria FDA-2000-D-0187 FDA Notice NAD-Notice of Availability of Data 2000-06-14T04:00:00Z 2000 6 2000-06-14T04:00:00Z 2000-09-07T03:59:59Z 2008-04-25T01:14:48Z   0 0 09000064804d2c71

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
Powered by Datasette · Queries took 285.98ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API